Patients with Hodgkin's disease: Clinical and pathological evaluation

dc.contributor.authorAltintaş A.
dc.contributor.authorÇil T.
dc.contributor.authorKaplan M.A.
dc.contributor.authorAtay A.E.
dc.contributor.authorIşikdoğan A.
dc.contributor.authorBüyükbayram H.
dc.contributor.authorAyyildiz O.
dc.date.accessioned2024-04-24T18:43:38Z
dc.date.available2024-04-24T18:43:38Z
dc.date.issued2006
dc.departmentDicle Üniversitesien_US
dc.description.abstractHodgkins' disease accounts 25% of all lymphoid malignancies and 1% of all cancers. In this study, 150 patients with Hodgkins' disease were reviewed retrospectively and compared according to age, gender, histopathologic subtype and stage of disease. 102 (68%) of patients were male and 48 (32%) were female with a median age of 41 (16-73) years. The frequencies of histopathological subtypes, mixed cellularity, nodular sclerosis, lymphocyte-rich and lymphocyte-depletion, were 63 (42%), 37 (24.6%), 25 (16.6%) and 21 (14%), respectively. Histological subtype was not determined in 4 (2.7%) patients. Distribution of patients according to stages were; 18 (12%) patients were in stage I, 35 (23.3%) patients were in stage II, 52 (34.7%) patients were in stage III and 43 (28.7%) patients were in stage IV. Sufficient staging procedure was not performed in two patients. SPSS 11.0 program was used for statistical analyzes. Patients were divided into two groups; older and younger than 40 years age and no statistical significancy was detected between groups. Also there was no significant relation between histopathological subtype and age. In conclusion; Hodgkin disease predominantly seen in males (M/F: 2.1). Mixed celularity HD was the most frequent subtype and 63.7% of our patients were in advanced stage (stage III ve IV).en_US
dc.identifier.endpage171en_US
dc.identifier.issn1306-133X
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-33845978040en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage165en_US
dc.identifier.urihttps://hdl.handle.net/11468/24243
dc.identifier.volume16en_US
dc.indekslendigikaynakScopus
dc.language.isotren_US
dc.relation.ispartofUHOD - Uluslararasi Hematoloji-Onkoloji Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHodgkins' Diseaseen_US
dc.subjectLymphomaen_US
dc.subjectLymphoproliferative Diseaseen_US
dc.titlePatients with Hodgkin's disease: Clinical and pathological evaluationen_US
dc.title.alternativeHodgkin lenfoma olgularimiz: Klinik ve patolojik değerlendirmeen_US
dc.typeArticleen_US

Dosyalar